ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,532.30
0.45%
S&P ASX All Technology
3,983.90
1.06%
Brent Oil
76.385
0.00%
US Dollar vs AUD
1.60334
0.00%
Bitcoin
100,404.82
-0.26%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Palvella Therapeutics Inc (PVLA) Share Price

Palvella Therapeutics Inc

Palvella Therapeutics Inc (PVLA)

NASDAQ
13.00
-0.50
(-3.70%)
Closed 02 February 8:00AM
Delayed by 15 minutes
13.04
0.04
(0.31%)
After Hours: 11:59AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
13.00
Bid
11.82
Offer
15.01
Volume
25,541
12.90 Day's Range 13.79
11.10 52 Week Range 15.67
Market Cap
17.163M
Previous Close
13.50
Open
13.23
Last Trade
257
@
13
Last Trade Time
Financial Volume
US$ 339,399
VWAP
13.2884
Average Volume (3m)
40,316
Shares Outstanding
1,320,240
Dividend Yield
-
PE Ratio
-0.15
Earnings Per Share (EPS)
-87.55
Revenue
6.15M
Net Profit
-115.59M

About Palvella Therapeutics Inc

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of mol... Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343, and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm functions through the region of the United States. Show more

Sector
General Indl Mach & Eq, Nec
Industry
Blank Checks
Website
www.sarcos.com
Headquarters
Wilmington, Delaware, USA
Founded
2021
Palvella Therapeutics Inc is listed in the General Indl Mach & Eq sector of the NASDAQ with ticker PVLA. The last closing price for Palvella Therapeutics was US$13.50. Over the last year, Palvella Therapeutics shares have traded in a share price range of US$ 11.10 to US$ 15.67.

Palvella Therapeutics currently has 1,320,240 shares in issue. The market capitalisation of Palvella Therapeutics is US$17.82 million. Palvella Therapeutics has a price to earnings ratio (PE ratio) of -0.15.

Ask ADVFN Intelligence (AI)

PVLA Latest News

More News

Form 424B3 - Prospectus [Rule 424(b)(3)]

18 January 2025
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

17 January 2025
Edgar (US Regulatory)

Palvella Therapeutics Announces Publication of Results from Phase 2 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations in the Journal of Vascular Anomalies

Publication reports 100% of participants were either “Much Improved” or “Very Much Improved” as rated by the Clinician Global Impression of Change following 12-weeks of QTORIN™ rapamycin FDA...

11 January 2025
GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

09 January 2025
Edgar (US Regulatory)

Palvella Therapeutics Announces First Patients Dosed in Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations

Phase 2 single-arm, baseline-controlled trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the treatment of cutaneous venous malformations (cutaneous VMs) to enroll...

09 January 2025
GlobeNewswire Inc.

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

07 January 2025
Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933

31 December 2024
Edgar (US Regulatory)

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

21 December 2024
Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

21 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 December 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.21.562512.814.6212.13148813.17192132CS
41.119.3355761143811.8915.6711.894340613.66980759CS
12-0.64-4.6920821114413.6415.6711.14031613.17384682CS
26-0.64-4.6920821114413.6415.6711.14031613.17384682CS
52-0.64-4.6920821114413.6415.6711.14031613.17384682CS
156-0.64-4.6920821114413.6415.6711.14031613.17384682CS
260-0.64-4.6920821114413.6415.6711.14031613.17384682CS

PVLA - Frequently Asked Questions (FAQ)

What is the current Palvella Therapeutics share price?
The current share price of Palvella Therapeutics is US$ 13.00
How many Palvella Therapeutics shares are in issue?
Palvella Therapeutics has 1,320,240 shares in issue
What is the market cap of Palvella Therapeutics?
The market capitalisation of Palvella Therapeutics is USD 17.82M
What is the 1 year trading range for Palvella Therapeutics share price?
Palvella Therapeutics has traded in the range of US$ 11.10 to US$ 15.67 during the past year
What is the PE ratio of Palvella Therapeutics?
The price to earnings ratio of Palvella Therapeutics is -0.15
What is the cash to sales ratio of Palvella Therapeutics?
The cash to sales ratio of Palvella Therapeutics is 2.8
What is the reporting currency for Palvella Therapeutics?
Palvella Therapeutics reports financial results in USD
What is the latest annual turnover for Palvella Therapeutics?
The latest annual turnover of Palvella Therapeutics is USD 6.15M
What is the latest annual profit for Palvella Therapeutics?
The latest annual profit of Palvella Therapeutics is USD -115.59M
What is the registered address of Palvella Therapeutics?
The registered address for Palvella Therapeutics is 108 W. 13TH STREET SUITE 100, WILMINGTON, DELAWARE, 19801
What is the Palvella Therapeutics website address?
The website address for Palvella Therapeutics is www.sarcos.com
Which industry sector does Palvella Therapeutics operate in?
Palvella Therapeutics operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
731.1M
REBNReborn Coffee Inc
US$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
US$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
US$ 1.54
(56.50%)
13.87M
CYCNCyclerion Therapeutics Inc
US$ 3.92
(54.33%)
82.57M
ENVBEnveric Biosciences Inc
US$ 2.0899
(-46.41%)
1.58M
NIVFNewGenIvf Group Ltd
US$ 0.1489
(-42.51%)
14.91M
GLSTGlobal Star Acquisition Inc
US$ 8.83
(-39.10%)
23.93k
PRPHProPhase Labs Inc
US$ 0.2633
(-38.02%)
900.48k
SPGCSacks Parente Golf Inc
US$ 0.5601
(-37.86%)
7.42M
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
731.1M
NVDANVIDIA Corporation
US$ 120.07
(-3.67%)
388.5M
RIMEAlgorhythm Holdings Inc
US$ 0.02565
(5.12%)
341.8M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1938
(30.77%)
237.15M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0355
(-11.25%)
236.44M

PVLA Discussion

View Posts
$oldier Hard $oldier Hard 3 months ago
$PIRS heavy volume day
👍️0
Monksdream Monksdream 5 months ago
PIRS under $20
👍️0
$oldier Hard $oldier Hard 6 months ago
$PIRS low O/S merger. Held on to a few of these just for giggles.
👍️0
Monksdream Monksdream 7 months ago
PIRS under $10
👍️0
Renee Renee 9 months ago
PIRS: Effective April 23,2024 a one for 80 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php
👍️0
$oldier Hard $oldier Hard 10 months ago
Mine went off at .265. Back on watch again.
👍️0
Monksdream Monksdream 10 months ago
Wash trade in progress
👍️0
$oldier Hard $oldier Hard 11 months ago
$PIRS no resistance up to .27 imo and a large gap above that.
👍️0
glenn1919 glenn1919 12 months ago
PIRS...................................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783
👍️0
Sjam410 Sjam410 1 year ago
Big sale PM
👍️0
Sjam410 Sjam410 1 year ago
Someone picked up a nice size at the close
👍️0
Sjam410 Sjam410 1 year ago
Agreed. Picked up more shares today
👍️0
Klinsmann Klinsmann 1 year ago
Jep, nice consolidation and may explode again on further updates
👍️0
Sjam410 Sjam410 1 year ago
Anyone still watching this?
👍️0
Klinsmann Klinsmann 1 year ago
There was one in the high 0.30´s, looks like it gets successfully taken down, but still could get rejected to 0.33 again. Gap in the high 0.70´s, and am not a pumper to talk about even more... I like this stock most because it takes every single step up perfectly and draws a perfect chart!
👍️0
Nextbigone Nextbigone 1 year ago
What resistance levels $1-1.20?
👍️0
Klinsmann Klinsmann 1 year ago
Break that resistance and we gonna have the best play of the month…
👍️0
Klinsmann Klinsmann 1 year ago
Hope some of you loaded with me under 0.25. It’s go time, support at the 50ma, maybe it’s possible to go for the 0.40 break this week…
👍️0
Klinsmann Klinsmann 1 year ago
Break these 0.40‘s to the 0.78 gap. On the expected updates everything possible…
👍️0
glenn1919 glenn1919 1 year ago
PIRS....................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783
👍️0
ANTI-BAGHOLDER ANTI-BAGHOLDER 1 year ago
Interesting news. https://www.otcmarkets.com/stock/PIRS/news/story?e&id=2608442
👍️0
Klinsmann Klinsmann 1 year ago
Time for the final loading before the big bang...
👍️0
Klinsmann Klinsmann 2 years ago
They got a patent renewed - but still no real PR on it while similar stocks moved 100%+ on it. Still holding…
👍️0
budapestjs budapestjs 2 years ago
Hey, are you able to share what the patent news is that you mentioned?
👍️0
Klinsmann Klinsmann 2 years ago
Golden opp.here - patent news and still under radar
👍️0
glenn1919 glenn1919 2 years ago
PIRS.........................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783
👍️0
Triple nickle Triple nickle 2 years ago
.22 settle
👍️0
$oldier Hard $oldier Hard 2 years ago
$PIRS nice 70% pop!
👍️0
Triple nickle Triple nickle 2 years ago
Off .25
👍️0
glenn1919 glenn1919 2 years ago
PIRS.....................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 years ago
PIRS......................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783
👍️0
TheFinalCD TheFinalCD 2 years ago
PIRS .20 https://finance.yahoo.com/news/were-little-worried-pieris-pharmaceuticals-142856056.html
👍️0
willlbone willlbone 2 years ago
Bid mid teens.
👍️0
$oldier Hard $oldier Hard 2 years ago
I see that now. Quite a beating still taking. Gonna watch it to find a bottom and maybe purchase a few back.
👍️0
TheFinalCD TheFinalCD 2 years ago
PIRS .25 -71%
👍️0
$oldier Hard $oldier Hard 2 years ago
$PIRS doing well now but a volatile day or sure.
👍️0
budapestjs budapestjs 2 years ago
Pfizer buying out our partner Seagen
👍️0
$oldier Hard $oldier Hard 2 years ago
$PIRS breaking above the 200. Might pull back some.
👍️0
$oldier Hard $oldier Hard 2 years ago
$PIRS doin awesome! Keep it up.
👍️0
$oldier Hard $oldier Hard 2 years ago
$PIRS back in at $1.00
👍️0
$oldier Hard $oldier Hard 3 years ago
I'm having trouble now too. It popped up on Ameritrade think or swim platform.
👍️0
budapestjs budapestjs 3 years ago
Hey, do you have a link for the patent news? I'm having trouble finding it. Thanks a lot.
👍️0
$oldier Hard $oldier Hard 3 years ago
$PIRS good patent news just popped.
👍️0
NoobyDoo NoobyDoo 3 years ago
picked up a few hundred shares today, figured it to be on sale will watch and add as needed.
👍️0
$oldier Hard $oldier Hard 3 years ago
$PIRS nice move today.
👍️0
$oldier Hard $oldier Hard 3 years ago
Rollin
👍️0
NoobyDoo NoobyDoo 3 years ago
What a nice buying opportunity today is, and maybe just a couple more days to load up before the next run! See if it bottoms around the 200 dma - watching closely...
👍️0
$oldier Hard $oldier Hard 3 years ago
I also bought back a few today. Just curious of what their intentions are now my friend. Bouncing off the 200 today might be what was needed. I sold them all back when it broke $6.00 and have been waiting. Sorry about your dad.
👍️0
NoobyDoo NoobyDoo 3 years ago
Added more in low 3.90's - if they try and bring it to the 200 day ma I'll add again! Long and strong! My dad passed from IPF, and it would be nice if PRS-220 is successful for all those that suffer from this disease with no cure or approved effective treatment.
👍️0
$oldier Hard $oldier Hard 3 years ago
Close to reload, agreed my friend.
👍️0

Your Recent History

NASDAQ
PVLA
Palvella Therapeutics
NASDAQ
IPHI
Inphi
BIT
UC4KSR
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads